MicroVision Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
MicroVision (NASDAQ:MVIS) reported a net loss of $14.2 million for Q2 2025, a 41% improvement from Q2 2024, with an EPS of $0.056, beating expectations by 7.7%. However, revenue fell short of analyst estimates by 74%. Looking ahead, revenue is projected to grow by 89% annually over the next three years, significantly outpacing the US Electronic industry’s 8.1% growth forecast. The company's share price remains stable, but there are four warning signs to consider.
MicroVision (NASDAQ:MVIS) Second Quarter 2025 Results
Key Financial Results
- Net loss: US$14.2m (loss narrowed by 41% from 2Q 2024).
- US$0.056 loss per share (improved from US$0.12 loss in 2Q 2024).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
MicroVision EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 74%. Earnings per share (EPS) exceeded analyst estimates by 7.7%.
Looking ahead, revenue is forecast to grow 89% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Electronic industry in the US.
Performance of the American Electronic industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 4 warning signs for MicroVision (1 can't be ignored!) that you need to be mindful of.
